Navigation Links
Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
Date:10/15/2007

, rater-blinded study that will compare alemtuzumab to Rebif(R) as first-line therapy for patients with relapsing-remitting multiple sclerosis (MS). The second Phase 3 study, CARE-MS II, also has begun and will enroll patients who have continued to experience relapse episodes while on currently available disease-modifying therapies.

Phase 2 Trial Design

The phase 2 trial randomized 334 patients with active relapsing-remitting multiple sclerosis at 49 medical centers in Europe and the United States. Patients in the trial were treated with alemtuzumab at one of two doses (12 or 24/mg per day intravenously for five days at initial treatment, and three days of re-treatment after 12 months with an option to treat again at 24 months), or interferon beta-1a (44 mcg administered by subcutaneous injection three times per week, as indicated in its product label).

The randomized trial compared the efficacy of alemtuzumab with interferon beta-1a using two primary endpoints: the rate of relapse of MS symptoms, and the time to Sustained Accumulation of Disability over six months as measured by Expanded Disability Status Scale [EDSS]. Efficacy assessments were made by independent neurologists blinded to therapy.

Alemtuzumab is an investigational drug for the treatment of MS and must not be used outside of a formal clinical trial setting in MS patients. Physicians or patients seeking additional information about the recently-initiated CARE-MS I Phase 3 trial should contact Genzyme Medical Information at 1-800-745-4447, option 2 in the United States, + 31 35 6991499 in Europe, or visit http://www.clinicaltrials.gov.

About Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic, debilitating disease in which the immune system attacks the person's brain and spinal cord. The disease causes a wide range of symptoms including fatigue, difficulty walking, numbness, and vision problems, and can pr
'/>"/>

SOURCE Genzyme Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
2. Medivation to Host Conference Call to Discuss Top-Line 12-Month Results From Dimebon Alzheimers Disease Study
3. Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line Results with ...
4. Evotec Reports Positive Proof-of-Concept Top-Line Results with Insomnia Drug Candidate EVT 201
5. Peregrine Pharmaceuticals Reports Positive Top-Line Results in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
6. Catalyst Pharmaceutical Partners, Inc. Announces Top-Line Results of Its Bioequivalence Study of CPP-109 (Vigabatrin), the Companys Investigational Drug to Treat Cocaine and Methamphetamine Addiction
7. Cobalis Expects to Report Phase III Top-Line Results in May
8. XenoPort Reports Positive Top-Line Phase 3 Trial Results of XP13512 in Restless Legs Syndrome
9. Amarin Reports Top-Line Results of two Phase III Studies of Miraxion in Huntingtons Disease
10. UCB Announces Positive Top-Line Phase III Results for Keppra as Adjunctive Therapy for Partial Onset Seizures in Paediatric Patients from One Month to Less than Four Years of Age
11. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Dose Escalation Trial with Tovaxin for Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 Mauna ... the multidisciplinary confocal laser endomicroscopy platform, announced today ... Ministry of Health, Labor and Welfare ... solution, the AQ-Flex 19 miniprobe.   ... 19 miniprobe is comprised of a fiber-optic microscope ...
(Date:7/6/2015)... , July 6, 2015  Protiviti, a global consulting ... Internal Auditing around the World publication ( www.protiviti.com/iaworld ... and reported on the evolution of the internal audit ... the globe as a means to providing senior executives ... this strategic business function. The 2015 edition ...
(Date:7/6/2015)... June 29, 2015 Research ... the "Pharmaceutical Grade Sodium Chloride Market by Applications, ... report to their offering. The pharmaceutical ... CAGR of 6.9% between 2014 and 2019 in terms ... 690 KT by 2019. The report on ...
Breaking Medicine Technology:Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3New Edition of Internal Auditing Around the World from Protiviti Explores Changes and Trends 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3
... N.J., May 16, 2011 New Jersey Center for ... in the nation to treat advanced prostate cancer patients ... class known as autologous cellular immunotherapies.  PROVENGE was approved ... the treatment of men with asymptomatic or minimally symptomatic ...
... public health, and regulatory highlights for this week from the ... designed for credentialed journalists. Release dates and times for items ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) FDA News & Notes ... legal limitations. Events and Speeches for ...
Cached Medicine Technology:New Jersey Center for Prostate Cancer & Urology Among First in Nation to Treat Advanced Prostate Cancer Patients with PROVENGE 2FDA News & Notes - Week of May 16, 2011 2FDA News & Notes - Week of May 16, 2011 3
(Date:7/6/2015)... ... , ... Olive Fertility Centre is proud to announce that Olive medical director ... of the department of Family Practice. , “This award is a real honour,” says ... technology is changing so rapidly and we are also developing new models of patient-centred ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... in southern California, has partnered with Woodbridge Walk-In Urgent Care to offer on-site ... and other serious medical conditions. Screenings are affordable and accurate and run about ...
(Date:7/6/2015)... ... ... Health care systems and genomics projects have generated massive patient data sets ... this “Big Data” to improve health and cut costs is now on the horizon, ... Health System in New York City. Physicians will have these new capabilities within two ...
(Date:7/6/2015)... ... July 06, 2015 , ... In a split second, breaking a bone can ... of having a fracture through the bone health screenings conducted by American Bone Health ... participating because our residents need this information to remain independent and strong for many ...
(Date:7/6/2015)... Los Angeles, CA (PRWEB) , ... July 06, 2015 , ... ... now offering patients the opportunity to achieve their ideal appearance through comprehensive treatment solutions. ... discuss their goals with the doctor and receive a plan that resolves each of ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 2Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 3Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 4Health News:Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer 5Health News:National Bone Health Screening and Awareness Day 2Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2
... Diagnostic X-rays may increase the risk of developing ... at the University of California, Berkeley,s School of Public ... with acute lymphoid leukemia (ALL) had almost twice the ... X-rays compared with children who did not have leukemia. ...
... Burton, MD, FAAP, will serve as the 2010-2011 president ... Oct. 4, at the AAP National Conference and Exhibition ... AAP is the nation,s largest pediatric organization with a ... and pediatric surgical specialists. Dr. Burton will ...
... Studies have shown a high rate of depression among ... if any. To address this issue, researchers at Rhode ... depression care protocol in home health care. The early ... the 29th Annual Meeting and Exposition of the National ...
... FRANCISCO The stresses of poverty have long been ... presented Sunday, Oct. 3, at the American Academy of ... researchers directly linked an increased unemployment rate to child ... statistics from the Bureau of Labor Statistics, and compared ...
... , FRIDAY, Oct. 1 (HealthDay News) -- ,In yet another ... healthy for the heart. The current research found that when ... of sudden cardiac death dropped by 36 percent. However, when ... day, they upped their risk of sudden cardiac death by about ...
... a mid-sized hospital were able to increase productivity and ... general technologist productivity, according to a study in the ... of Radiology ( www.jacr.org ). "Improving productivity ... may be difficult to achieve simultaneously," said C. Daniel ...
Cached Medicine News:Health News:X-rays linked to increased childhood leukemia risk 2Health News:X-rays linked to increased childhood leukemia risk 3Health News:X-rays linked to increased childhood leukemia risk 4Health News:O. Marion Burton, M.D., F.A.A.P., addresses American Academy of Pediatrics in new term as president 2Health News:Can telemedicine improve geriatric depression? 2Health News:Moderate Alcohol Use Helps Prevent Sudden Cardiac Death: Study 2Health News:Moderate Alcohol Use Helps Prevent Sudden Cardiac Death: Study 3
... to quality patient care., ,S/5 Anesthesia ... to anesthesia delivery. As part of the ... features, electronically controlled gas delivery and agent ... to create a truly integrated system. The ...
... Tegagel hydrogel wound filler and ... are amorphous hydrogel dressings specially formulated ... that has been shown to enhance ... formula meets clinical needs for management ...
... SS is a complete physician preference card ... management system for all the supply management ... preference card system combined with a broad ... entire case cart and operating suite supply ...
Easy to Use manual vacuum system features a pumping mechanism that can be operated with one hand....
Medicine Products: